{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:36:19Z","timestamp":1791311779852,"version":"4.3.1"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"abstract":"<jats:p>OBJECTIVE. Streptococcus agalactiae (group B Streptococcus) is an important cause of morbidity and mortality in newborn infants. So far, there have been no published data on the incidence, morbidity, and mortality of invasive neonatal group B Streptococcus infections in Germany.<\/jats:p><jats:p>METHODS. A prospective active surveillance study involving all of the pediatric hospitals, which reported their cases to the German Pediatric Surveillance Unit, and all of the microbiological laboratories serving pediatric hospitals, which reported their cases to the Laboratory Sentinel Group at Robert Koch Institute Berlin, was conducted between 2001 and 2003. Capture-recapture analysis was used to evaluate the completeness of reported neonatal invasive group B Streptococcus infections.<\/jats:p><jats:p>RESULTS. We collected and analyzed data from 347 and 360 infants with invasive group B Streptococcus infection during the first 3 months of life, as reported by pediatricians to the German Pediatric Surveillance Unit and microbiologists to the Robert Koch Institute Berlin, respectively. Using capture-recapture analysis, we calculated an incidence of 0.47 per 1000 live births. Nearly 60% of the infants suffered from early-onset disease, and 16% of these presented with meningitis. In contrast, 61.8% of infants with late-onset disease presented with meningitis. Prematurity was present in 22.4% of early-onset disease and 39.7% of late-onset disease cases, respectively. A high proportion of infants suffered from sequelae because of group B Streptococcus infection at the time of discharge from the hospital. Most common sequelae were hydrocephalus and cerebral seizure. Case fatality rate was 4.3%.<\/jats:p><jats:p>CONCLUSIONS. This study, which is the first to provide information on the current national incidence and morbidity of invasive group B Streptococcus infection in Germany, demonstrates remarkable country-specific variation in comparison with other European countries, which gather data in a similar fashion. Therefore, the importance of country-specific prevention guidelines has to be stressed.<\/jats:p>","DOI":"10.1542\/peds.2005-2481","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T01:40:40Z","timestamp":1147138840000},"page":"e1139-e1145","source":"Crossref","is-referenced-by-count":87,"title":["Incidence and Clinical Presentation of Invasive Neonatal Group B Streptococcal Infections in Germany"],"prefix":"10.1542","volume":"117","author":[{"given":"Kirsten","family":"Fluegge","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Siedler","sequence":"additional","affiliation":[{"name":"Robert Koch Institute, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Heinrich","sequence":"additional","affiliation":[{"name":"German Pediatric Surveillance Unit Office, University Children's Hospital, Du\u0308sseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Schulte-Moenting","sequence":"additional","affiliation":[{"name":"Department of Biometry and Medical Statistics, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jantje","family":"Moennig","sequence":"additional","affiliation":[{"name":"Perinatal Infectious Disease Epidemiology Unit, Departments of Obstetrics and Pediatrics, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee B.","family":"Bartels","sequence":"additional","affiliation":[{"name":"Perinatal Infectious Disease Epidemiology Unit, Departments of Obstetrics and Pediatrics, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Dammann","sequence":"additional","affiliation":[{"name":"Perinatal Infectious Disease Epidemiology Unit, Departments of Obstetrics and Pediatrics, Hannover Medical School, Hannover, Germany"},{"name":"Neuroepidemiology Unit, Department of Neurology, Children's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"von Kries","sequence":"additional","affiliation":[{"name":"Institute for Social Pediatrics and Adolescent Medicine, Ludwig Maxilimilians University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Berner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the German Pediatric Surveillance Unit Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,6,1]]},"reference":[{"key":"2021120823000234900_R1","doi-asserted-by":"crossref","unstructured":"Schuchat A. Group B Streptococcus. Lancet.\u20081999;353:51\u201356","DOI":"10.1016\/S0140-6736(98)07128-1"},{"key":"2021120823000234900_R2","doi-asserted-by":"crossref","unstructured":"Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev.\u20081998;11:497\u2013513","DOI":"10.1128\/CMR.11.3.497"},{"key":"2021120823000234900_R3","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med.\u20082000;342:15\u201320","DOI":"10.1056\/NEJM200001063420103"},{"key":"2021120823000234900_R4","unstructured":"Centers for Disease Control and Prevention. Diminishing racial disparities in early-onset neonatal group B streptococcal disease: United States, 2000\u20132003. MMWR Morb Mortal Wkly Rep.\u20082004;53:502\u2013505"},{"key":"2021120823000234900_R5","doi-asserted-by":"crossref","unstructured":"Trijbels-Smeulders M, Gerards LJ, M PC, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands 1997\u201398. Paediatr Perinat Epidemiol.\u20082002;16:334\u2013341","DOI":"10.1046\/j.1365-3016.2002.00437.x"},{"key":"2021120823000234900_R6","doi-asserted-by":"crossref","unstructured":"Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet.\u20082004;363:292\u2013294","DOI":"10.1016\/S0140-6736(03)15389-5"},{"key":"2021120823000234900_R7","doi-asserted-by":"crossref","unstructured":"von Kries R, Heinrich B, Hermann M. Pa\u0308diatrische Epidemiologie in Deutschland: Forschungsinstrument ESPED (Erhebungseinheit fu\u0308r seltene pa\u0308diatrische Erkrankungen in Deutschland). Monatsschr Kinderheilkd.\u20082001;149:1191\u20131197","DOI":"10.1007\/s001120170044"},{"key":"2021120823000234900_R8","doi-asserted-by":"crossref","unstructured":"Hook EB, Regal RR. Capture-recapture estimation. Epidemiology.\u20081995;6:569\u2013570","DOI":"10.1097\/00001648-199509000-00023"},{"key":"2021120823000234900_R9","doi-asserted-by":"crossref","unstructured":"Andersen J, Christensen R, Hertel J. Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001. Acta Paediatr.\u20082004;93:1334\u20131339","DOI":"10.1111\/j.1651-2227.2004.tb02933.x"},{"key":"2021120823000234900_R10","doi-asserted-by":"crossref","unstructured":"Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J.\u20081999;18:806\u2013810","DOI":"10.1097\/00006454-199909000-00012"},{"key":"2021120823000234900_R11","doi-asserted-by":"crossref","unstructured":"Lopez Sastre JB, Fernandez Colomer B, Coto Cotallo GD, et al. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr.\u20082005;94:451\u2013457","DOI":"10.1111\/j.1651-2227.2005.tb01917.x"},{"key":"2021120823000234900_R12","doi-asserted-by":"crossref","unstructured":"Luck S, Torny M, d'Agapeyeff K, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet.\u20082003;361:1953\u20131954","DOI":"10.1016\/S0140-6736(03)13553-2"},{"key":"2021120823000234900_R13","doi-asserted-by":"crossref","unstructured":"Edwards MS, Rench MA, Haffar AA, Murphy MA, Desmond MM, Baker CJ. Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr.\u20081985;106:717\u2013722","DOI":"10.1016\/S0022-3476(85)80342-5"},{"key":"2021120823000234900_R14","doi-asserted-by":"crossref","unstructured":"Chin KC, Fitzhardinge PM. Sequelae of early-onset group B hemolytic streptococcal neonatal meningitis. J Pediatr.\u20081985;106:819\u2013822","DOI":"10.1016\/S0022-3476(85)80365-6"},{"key":"2021120823000234900_R15","doi-asserted-by":"crossref","unstructured":"Wald ER, Bergman I, Taylor HG, Chiponis D, Porter C, Kubek K. Long-term outcome of group B streptococcal meningitis. Pediatrics.\u20081986;77:217\u2013221","DOI":"10.1542\/peds.77.2.217"},{"key":"2021120823000234900_R16","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep.\u20082002;51:1\u201322"},{"key":"2021120823000234900_R17","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol.\u20082002;100:1405\u20131412","DOI":"10.1097\/00006250-200212000-00044"},{"key":"2021120823000234900_R18","doi-asserted-by":"crossref","unstructured":"Trijbels-Smeulders M, Adriaanse AH, Gerards LJ, et al. Prevention strategy for neonatal early-onset group-B-streptococcal (GBS) disease in the Netherlands. Rev Med Microbiol.\u20082003;14:35\u201339","DOI":"10.1097\/00013542-200301000-00004"},{"key":"2021120823000234900_R19","unstructured":"Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease. R Coll Obstet Gynecol Guideline.36; 2003:1\u201310"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/6\/e1139\/1072488\/zpe006060e1139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/6\/e1139\/1072488\/zpe006060e1139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T10:54:29Z","timestamp":1683456869000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/6\/e1139\/69445\/Incidence-and-Clinical-Presentation-of-Invasive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,6,1]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-2481","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}